Egypt continues to assert its leadership in the regional pharmaceutical industry, producing approximately…
Egypt's pharmaceutical sector reached a valuation of $6.21 billion in 2024, marking a 43% year-on-year growth, positioning it as one of the fastest-growing markets in the Middle East and Africa.…
The agreement was signed by Ashraf El-Khouly, Executive Managing Director of the Egyptian Holding Company for Pharmaceuticals—affiliated with the Ministry of Public Enterprise Sector—and Hossam Abdel Maksoud, Chairman of Dawah…
